Alzheimer's drugs rejected for NHS use in 'painful setback' for dementia patients
Two drugs – donanemab and lecanemab – have been rejected for NHS use because their benefits are "too small" to justify their cost
Continue reading this article about Alzheimer's drugs rejected for NHS use in 'painful setback' for dementia patients
by Bethan Finighan
NHS Forums - For daily discussion by NHS Staff.

Two drugs – donanemab and lecanemab – have been rejected for NHS use because their benefits are "too small" to justify their cost
Continue reading this article about Alzheimer's drugs rejected for NHS use in 'painful setback' for dementia patients
by Bethan Finighan
NHS Forums - For daily discussion by NHS Staff.